Company intelligence / Profile preview

BioChain Institute

Newark, California, United Statesbiochain.com ↗

Ownership: Private
Development stage: Commercial

Overview

BioChain Institute is a leading provider of high-quality biospecimens, reference standards, kits, reagents, and spatial biology multiomics services. Their offerings support research in genomics, proteomics, molecular diagnostics, translational medicine, and precision medicine. They are trusted by major pharmaceutical companies and academic institutions worldwide.

Modalities: Not directly applicable (company provides biospecimens, reagents, and analytical services rather than developing therapeutics)
Industry: Non-Drug Biotech

Partnerships

Enable Medicine (spatial biology solutions partnership)Molecular Instruments (RNA detection technology partnership)

Beyond the preview

Go deeper on BioChain Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioChain Institute.

Explore the full profile